Northeast Atrial Fibrillation Webinars

Updated:Sep 19,2017

The American Heart Association / American Stroke Association Northeast Quality Improvement Team:
Atrial fibrillation is the most common sustained cardiac rhythm disturbance while the associated hemodynamic impairment and thromboembolic events result in significant morbidity, mortality, and cost.

Consistent adherence to current evidence based guidelines and systems in place for performance and outcome feedback are important steps in improving care and outcomes for this population.

Thank you for joining us for this four part webinar series for the latest in atrial fibrillation and atrial flutter treatment.
Atrial Fibrillation - Synchronizing Patient Care with Treatment Guidelines - Webinar Series
American Heart Associatio/American Stroke Association - Get With The Guidelines A Fib

Enduring Dates:  If you were unable to participate in these live web conferences, and would like to view them online and receive continuing education credits, please logon to Sign in with your username and password. If you don't have an existing account, please sign up for one. Please avoid creating a new account if you have created one in the past, as duplicate accounts may cause errors with claiming continuing education credits. Go to the Course Catalog tab > Delivery Methods > Online Courses > Webinars and Webcasts, and click on "enroll" on your online course. Each webinar will be available for one year post the live broadcast.

Wednesday, September 11, 2013 -- 12:00-1:15 pm EST
Introduction and Overview of the Management of Patients with Atrial Fibrillation and Atrial Flutter

Albert L. Waldo, MD, FAHA
The Walter H. Pritchard Professor of Cardiology, Professor of Medicine, and Professor of Biomedical Engineering Case Western Reserve University
This presentation provides an introduction to treatment and management of patients with atrial fibrillation and flutter including risk factors, classification and interactions of atrial fibrillation and flutter, the clinical evaluation and an overview of the priorities in atrial fibrillation and flutter management.

Learning Objectives:
• Explain the definition and classification of atrial fibrillation and atrial flutter and the impact on treatment and management decisions.
• Discuss the components of the clinical evaluation of a patient with atrial fibrillation and atrial flutter.

Wednesday, September 25, 2013 -- 12:00-1:15 pm EST
Anticoagulation Therapy and Thromboembolism Prevention in Patients with Atrial Fibrillation and Atrial Flutter

Jonathan L. Halperin, MD, FAHA, FACC

Professor of Medicine Mount Sinai Medical Center New York, NY
This presentation covers prevention of thromboembolism in patients with atrial fibrillation and flutter including risk stratification to guide selection of antithrombotic therapy, the new oral anticoagulants including advantages and disadvantages, potential barriers to uptake and implications for cardiovascular practice.

Learning Objectives:
• List 5 risk factors for ischemic stroke and thromboembolism in patients with non-valvular atrial fibrillation.
• Identify advantages of the new oral anticoagulant drugs.

Wednesday, October 9, 2013 -- 12:00-1:15 pm EST
Rhythm Control of Patients with Atrial Fibrillation and Atrial Flutter

N.A. Mark Estes, III, MD, FAHA
Professor of Medicine Tufts University School of Medicine Boston, MA
This presentation highlights options for rate control and rhythm control, benefits and limitations of pharmacologic and non-pharmacologic approaches and selection of patients for a strategy of rate control versus rhythm control based on symptoms.

Learning Objectives:
• Discuss pharmacologic and non-pharmacologic options for rhythm and rate control
• Discuss the clinical criteria used to decide on a rate control versus rhythm control strategy

Wednesday, October 23, 2013 -- 12:00-1:15 pm EST
Special Considerations: Management of Atrial Fibrillation in Special Populations and Comorbid Conditions
Presented Through Case Studies

Michael D. Ezekowitz, MD, PhD
Professor of Medicine, Jefferson Medical College
This presentation presented in a case study format covers special considerations in the treatment and management of atrial fibrillation including special populations as well as comorbid conditions.

Learning Objectives:
• List 3 conditions that require special consideration in treatment of atrial fibrillation
• Discuss the considerations for treatment of atrial fibrillation in pregnancy

Target Audience:  Physicians (ED, Cardiologists, Hospitalists/Internal Medicine); Nurses, Nurse Practitioners and Physician’s Assistants.

Disclosure Policy: All persons who develop and/or control educational content in CME activities sponsored by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials. List of Faculty and Planning Committee Disclosures (PDF)